glp 1 for crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential GLP-1 Receptor Agonists Well Tolerated
Description
In this episode of the CenExel Insights Podcast, Beth DeLuca, BS, RD, Director of Marketing and Patient Recruitment, shares how strategic patient support can strengthen retention and elevate trial performance
Learn when to increase your semaglutide or tirzepatide dose
GLP-1 receptor agonist therapy no longer requires insurance coverage or expensive clinic visits
Other days, nothing sounds appealing
Orforglipron (Foundayo) is a once-daily GLP-1 pill for weight loss
